Bolt Biotherapeutics/Prana Therapies Clinical Trials

If you are interested in participating in a clinical trial for one of our investigational medicines below, we encourage you to speak with your physician about the possibility of enrolling.

Program Phase Indication
PRA-216 2 Asthma

LEARN MORE AT CLINICALTRIALS.GOV*
PRA-216 2 Atopic Dermatitis

LEARN MORE AT CLINICALTRIALS.GOV*
PRA-216 2 COPD

LEARN MORE AT CLINICALTRIALS.GOV*
BDC-4182 1 Gastric and Gastroesophageal Cancer

LEARN MORE AT CLINICALTRIALS.GOV*

Visit clinicaltrials.gov to learn more about study participation including eligibility, risks and benefits of participation, the informed consent process, and questions to ask when considering study participation.

If you have questions about our clinical trials, please email us at clinicaltrials@boltbio.com.

Expanded Access Policy

At this time, participation in clinical trials is the only way to gain access to our investigational medicines. Bolt Biotherapeutics will review and update its policy on offering patients Expanded Access from time to time as additional clinical data becomes available.